Regulation & law · 30/11/2007Updated: 10/17/2026 · 1 min read
National Institutes of Health to Grant Exclusive License for HIV Resistance Diagnosis Kit
Summary
The National Institutes of Health is considering granting an exclusive license to AmiKana.BioLogics for the development of an FDA-approved HIV resistance diagnosis kit, based on a patent issued in 1998.
Original source language: Federal Register — All DocumentsOpen original release →